Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

Clinical trial NCT00790322 · COMPLETED

Trial details

NCT number: NCT00790322
Sponsor: Biotec Pharmacon ASA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer Oral Mucositis

Start date: 2008-10-01
Primary completion: 2010-02-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.